107 related articles for article (PubMed ID: 11226513)
21. Identification of the CD33-related Siglec receptor, Siglec-5 (CD170), as a useful marker in both normal myelopoiesis and acute myeloid leukaemias.
Virgo P; Denning-Kendall PA; Erickson-Miller CL; Singha S; Evely R; Hows JM; Freeman SD
Br J Haematol; 2003 Nov; 123(3):420-30. PubMed ID: 14617000
[TBL] [Abstract][Full Text] [Related]
22. Detection of molecular targets on the surface of CD34+/CD38-- stem cells in various myeloid malignancies.
Florian S; Sonneck K; Hauswirth AW; Krauth MT; Schernthaner GH; Sperr WR; Valent P
Leuk Lymphoma; 2006 Feb; 47(2):207-22. PubMed ID: 16321850
[TBL] [Abstract][Full Text] [Related]
23. CD133 (AC133) expression on AML cells and progenitors.
Vercauteren SM; Sutherland HJ
Cytotherapy; 2001; 3(6):449-59. PubMed ID: 11953029
[TBL] [Abstract][Full Text] [Related]
24. Primitive AML progenitors from most CD34(+) patients lack CD33 expression but progenitors from many CD34(-) AML patients express CD33.
Vercauteren S; Zapf R; Sutherland H
Cytotherapy; 2007; 9(2):194-204. PubMed ID: 17453971
[TBL] [Abstract][Full Text] [Related]
25. Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors.
Case J; Mead LE; Bessler WK; Prater D; White HA; Saadatzadeh MR; Bhavsar JR; Yoder MC; Haneline LS; Ingram DA
Exp Hematol; 2007 Jul; 35(7):1109-18. PubMed ID: 17588480
[TBL] [Abstract][Full Text] [Related]
26. Aberrant marker expression patterns on the CD34+CD38- stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission.
van Rhenen A; Moshaver B; Kelder A; Feller N; Nieuwint AW; Zweegman S; Ossenkoppele GJ; Schuurhuis GJ
Leukemia; 2007 Aug; 21(8):1700-7. PubMed ID: 17525725
[TBL] [Abstract][Full Text] [Related]
27. CD117 (c-kit) is a restricted antigen of acute myeloid leukemia and characterizes early differentiative levels of M5 FAB subtype.
Cascavilla N; Musto P; D'Arena G; Melillo L; Carella AM; Petrilli MP; Sanpaolo G; Carotenuto M
Haematologica; 1998 May; 83(5):392-7. PubMed ID: 9658721
[TBL] [Abstract][Full Text] [Related]
28. CD133-2 (AC141) expression analysis in acute leukemia immunophenotyping in correlation to CD34 and P-glycoprotein.
Guenova M; Balatzenko G
Hematology; 2008 Jun; 13(3):137-41. PubMed ID: 18702870
[TBL] [Abstract][Full Text] [Related]
29. High percentage of CD34-positive cells in autologous AML peripheral blood stem cell products reflects inadequate in vivo purging and low chemotherapeutic toxicity in a subgroup of patients with poor clinical outcome.
Feller N; Schuurhuis GJ; van der Pol MA; Westra G; Weijers GW; van Stijn A; Huijgens PC; Ossenkoppele GJ
Leukemia; 2003 Jan; 17(1):68-75. PubMed ID: 12529662
[TBL] [Abstract][Full Text] [Related]
30. Immunophenotypic profile of AC133-positive cells in bone marrow, mobilized peripheral blood and umbilical cord blood.
D'Arena G; Savino L; Nunziata G; Cascavilla N; Matera R; Pistolese G; Carella AM
Leuk Lymphoma; 2002 Apr; 43(4):869-73. PubMed ID: 12153177
[TBL] [Abstract][Full Text] [Related]
31. [The expression and clinical significance of early differentiation antigens in acute leukemia].
Zhou Y; Li Q; Meng HX; Wang YF; Yu Z; Qiu LG
Zhonghua Nei Ke Za Zhi; 2005 Jan; 44(1):46-9. PubMed ID: 15769398
[TBL] [Abstract][Full Text] [Related]
32. Expression, regulation and function of AC133, a putative cell surface marker of primitive human haematopoietic cells.
Majka M; Ratajczak J; Machalinski B; Carter A; Pizzini D; Wasik MA; Gewirtz AM; Ratajczak MZ
Folia Histochem Cytobiol; 2000; 38(2):53-63. PubMed ID: 10833669
[TBL] [Abstract][Full Text] [Related]
33. The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities.
Khalidi HS; Medeiros LJ; Chang KL; Brynes RK; Slovak ML; Arber DA
Am J Clin Pathol; 1998 Feb; 109(2):211-20. PubMed ID: 9583894
[TBL] [Abstract][Full Text] [Related]
34. Human immunodeficiency virus infection of human placental cord blood CD34+AC133+ stem cells and their progeny.
Hariharan D; Li Y; Campbell DE; Douglas SD; Starr SE; Ho W
AIDS Res Hum Retroviruses; 1999 Nov; 15(17):1545-52. PubMed ID: 10580405
[TBL] [Abstract][Full Text] [Related]
35. Acute myeloid leukemia with t(6;9) (p23;q34): association with myelodysplasia, basophilia, and initial CD34 negative immunophenotype.
Alsabeh R; Brynes RK; Slovak ML; Arber DA
Am J Clin Pathol; 1997 Apr; 107(4):430-7. PubMed ID: 9124211
[TBL] [Abstract][Full Text] [Related]
36. Identification and isolation from either adult human bone marrow or G-CSF-mobilized peripheral blood of CD34(+)/CD133(+)/CXCR4(+)/ Lin(-)CD45(-) cells, featuring morphological, molecular, and phenotypic characteristics of very small embryonic-like (VSEL) stem cells.
Sovalat H; Scrofani M; Eidenschenk A; Pasquet S; Rimelen V; Hénon P
Exp Hematol; 2011 Apr; 39(4):495-505. PubMed ID: 21238532
[TBL] [Abstract][Full Text] [Related]
37. Growth factor receptors in hematopoietic stem cells: EPH family expression in CD34+ and CD133+ cell populations from mobilized peripheral blood.
Lazarova P; Wu Q; Kvalheim G; Suo Z; Haakenstad KW; Metodiev K; Nesland JM
Int J Immunopathol Pharmacol; 2006; 19(1):49-56. PubMed ID: 16569339
[TBL] [Abstract][Full Text] [Related]
38. A functional hierarchy among the CD34+ hematopoietic cells based on in vitro proliferative and differentiative potential of AC133+CD34(bright) and AC133(dim/)-CD34+ human cord blood cells.
Goussetis E; Theodosaki M; Paterakis G; Peristeri J; Petropoulos D; Kitra V; Papassarandis C; Graphakos S
J Hematother Stem Cell Res; 2000 Dec; 9(6):827-40. PubMed ID: 11177594
[TBL] [Abstract][Full Text] [Related]
39. Comparative quantitative expression of bcl-2 by normal and leukaemic myeloid cells.
Bradbury DA; Russell NH
Br J Haematol; 1995 Oct; 91(2):374-9. PubMed ID: 8547078
[TBL] [Abstract][Full Text] [Related]
40. Differences between peripheral blood and cord blood in the kinetics of lineage-restricted hematopoietic cells: implications for delayed platelet recovery following cord blood transplantation.
Yasui K; Matsumoto K; Hirayama F; Tani Y; Nakano T
Stem Cells; 2003; 21(2):143-51. PubMed ID: 12634410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
